<List><item><source>MED</source><extId>29871853</extId><pmcid>PMC6008514</pmcid><annotations><annotation><prefix>trials.gov/ct2/show/</prefix><exact>NCT01964820</exact><postfix> (Archived by WebCit</postfix><tags><tag><name>NCT01964820</name><uri>http://identifiers.org/clinicaltrials/NCT01964820</uri></tag></tags><id>http://europepmc.org/abstract/MED/29871853#europepmc-b2c2e1c9f36d3a64ee17bebc8aeaa23c</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ClinicalTrials.gov </prefix><exact>NCT02861755</exact><postfix> (Phase 2); https://c</postfix><tags><tag><name>NCT02861755</name><uri>http://identifiers.org/clinicaltrials/NCT02861755</uri></tag></tags><id>http://europepmc.org/abstract/MED/29871853#europepmc-f119c36ad17e5284216e9233a2c30924</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>trials.gov/ct2/show/</prefix><exact>NCT02861755</exact><postfix> (Archived by WebCit</postfix><tags><tag><name>NCT02861755</name><uri>http://identifiers.org/clinicaltrials/NCT02861755</uri></tag></tags><id>http://europepmc.org/abstract/MED/29871853#europepmc-d87d6982b1dcce32e49cd1ae2b42f369</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ClinicalTrials.gov </prefix><exact>NCT01964820</exact><postfix> (Phase 1); https://c</postfix><tags><tag><name>NCT01964820</name><uri>http://identifiers.org/clinicaltrials/NCT01964820</uri></tag></tags><id>http://europepmc.org/abstract/MED/29871853#europepmc-df50c568ed44d93aca07b7d64a27c9f4</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>; phase 1 at UCSF (#</prefix><exact>NCT01964820</exact><postfix>) and phase 2 at Nor</postfix><tags><tag><name>NCT01964820</name><uri>http://identifiers.org/clinicaltrials/NCT01964820</uri></tag></tags><id>http://europepmc.org/articles/PMC6008514#europepmc-cf0782c5fbfca14cab2aeb4713713be0</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>phase 2 at Northwestern University (#</prefix><exact>NCT02861755</exact><postfix>). </postfix><tags><tag><name>NCT02861755</name><uri>http://identifiers.org/clinicaltrials/NCT02861755</uri></tag></tags><id>http://europepmc.org/articles/PMC6008514#europepmc-f6c0d5cfb15b4e30b88da7a6c68833ec</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>icaltrials.gov as # </prefix><exact>NCT01964820</exact><postfix> (phase 1 at Univers</postfix><tags><tag><name>NCT01964820</name><uri>http://identifiers.org/clinicaltrials/NCT01964820</uri></tag></tags><id>http://europepmc.org/articles/PMC6008514#europepmc-be4464058d83cf569c305767cff2c67d</id><type>Accession Numbers</type><section>Acknowledgments (http://purl.org/orb/Acknowledgments)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>San Francisco) and #</prefix><exact>NCT02861755</exact><postfix> (phases 2 and 3 at </postfix><tags><tag><name>NCT02861755</name><uri>http://identifiers.org/clinicaltrials/NCT02861755</uri></tag></tags><id>http://europepmc.org/articles/PMC6008514#europepmc-4ea0d698973bd5401b264328451ffbfc</id><type>Accession Numbers</type><section>Acknowledgments (http://purl.org/orb/Acknowledgments)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>